Abstract:Recent studies have discovered that tiny particles of microplastics (MPs) at the nano-scale level can enter the body of organisms from the environment, potentially causing metabolic ailments. However, further investigation is required to understand the alterations in the immune microenvironment associated with non-alcoholic fatty liver disease (NAFLD) occurrence following exposure to MPs. Experiments were performed using mice, which were given a normal chow or high-fat diet (NCD or HFD, respectively) plus free drinking of sterile water with or without MPs, respectively. Employing an impartial technique known as unbiased single-cell RNA-sequencing (scRNA-seq), the cellular (single-cell) pathology landscape of NAFLD and related changes in the identified immune cell populations induced following MPs plus HFD treatment were assessed. The results showed that mice in the HFD groups had remarkably greater NAFLD activity scores than those from the NCD groups. Moreover, administration of MPs plus HFD further worsened the histopathological changes in the mice's liver, leading to hepatic steatosis, inflammatory cell infiltrations and ballooning degeneration. Following the construction of a sing-cell resolution transcriptomic atlas of 43,480 cells in the mice's livers of the indicated groups, clear cellular heterogeneity and potential cell-to-cell cross-talk could be observed. Specifically, we observed that MPs exacerbated the pro-inflammatory response and influenced the stemness of hepatocytes during HFD feeding. Importantly, treatment with MPs significantly increase the infiltration of the infiltrating liver-protecting Vsig4+ macrophages in the liver of the NAFLD mouse model while remarkably decreasing the angiogenic S100A6+ macrophage subpopulation. Furthermore, mice treated with MPs plus HFD exhibited significantly increased recruitment of CD4+ cells and heightened exhaustion of CD8+ T cells than those from the control group, characteristics typically associated with the dysregulation of immune homeostasis and severe inflammatory damage. Overall, this study offers valuable perspectives into comprehending the potential underlying cellular mechanisms and regulatory aspects of the microenvironment regarding MPs in the development of NAFLD.

Toxicity of Microplastics and Plastic Additive Co-Exposure in Liver Disse Organoids from Healthy Donors and Patient-Derived Induced Pluripotent Stem Cells

Distinct toxicity of microplastics/TBBPA co-exposure to bioprinted liver organoids derived from hiPSCs of healthy and patient donors

Lipidomics and Transcriptomics Insight into Impacts of Microplastics Exposure on Hepatic Lipid Metabolism in Mice

Polystyrene microplastics induce hepatotoxicity and disrupt lipid metabolism in the liver organoids

Combined Effect of Polystyrene Microplastics and Bisphenol A on the Human Embryonic Stem Cells-Derived Liver Organoids: the Hepatotoxicity and Lipid Accumulation

Microplastic-induced hepatic adverse effects evaluated in advanced quadruple cell human primary models following three weeks of repeated exposure

The Hepatotoxicity Assessment of Micro/nanoplastics: A Preliminary Study to Apply the Adverse Outcome Pathways.

Liver Injury Induced by Exposure to Polystyrene Microplastics Alone or in Combination with Cadmium in Mice Is Mediated by Oxidative Stress and Apoptosis

The iron matters: Aged microplastics disrupted the iron homeostasis in the liver organoids

Single-cell transcriptome analysis of liver immune microenvironment changes induced by microplastics in mice with non-alcoholic fatty liver

Mitigation of polystyrene microplastic-induced hepatotoxicity in human hepatobiliary organoids through bile extraction

Application of organoid technology in the human health risk assessment of microplastics: A review of progresses and challenges

Dietary exposure to polystyrene microplastics exacerbates liver damage in fulminant hepatic failure via ROS production and neutrophil extracellular trap formation

Microplastics cause hepatotoxicity in diabetic mice by disrupting glucolipid metabolism via PP2A/AMPK/HNF4A and promoting fibrosis via the Wnt/β‐catenin pathway

Hepatic and metabolic outcomes induced by sub-chronic exposure to polystyrene microplastics in mice

Polystyrene microplastics exacerbated liver injury from cyclophosphamide in mice: Insight into gut microbiota

Polyethylene microplastics induced gut microbiota dysbiosis leading to liver injury via the TLR2/NF-κB/NLRP3 pathway in mice

Innovative explorations: unveiling the potential of organoids for investigating environmental pollutant exposure

Disturbed Gut-Liver Axis Indicating Oral Exposure to Polystyrene Microplastic Potentially Increases the Risk of Insulin Resistance

Microplastic-contaminated Antibiotics As an Emerging Threat to Mammalian Liver: Enhanced Oxidative and Inflammatory Damages

Proinflammatory properties and lipid disturbance of polystyrene microplastics in the livers of mice with acute colitis